These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19804981)
21. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues. Congiu C; Cocco MT; Onnis V Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978 [TBL] [Abstract][Full Text] [Related]
22. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. Huang HS; Chou CL; Guo CL; Yuan CL; Lu YC; Shieh FY; Lin JJ Bioorg Med Chem; 2005 Mar; 13(5):1435-44. PubMed ID: 15698759 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
24. Different roles of p53 in the regulation of DNA damage caused by 1,2-heteroannelated anthraquinones and doxorubicin. Chang YL; Lee HJ; Liu ST; Lin YS; Chen TC; Hsieh TY; Huang HS; Huang SM Int J Biochem Cell Biol; 2011 Dec; 43(12):1720-8. PubMed ID: 21856437 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles. Kumar D; Kumar NM; Chang KH; Gupta R; Shah K Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049 [TBL] [Abstract][Full Text] [Related]
26. Novel strategies for the synthesis of anthrapyran antibiotics: discovery of a new antitumor agent and total synthesis of (S)-espicufolin. Tietze LF; Gericke KM; Singidi RR; Schuberth I Org Biomol Chem; 2007 Apr; 5(8):1191-200. PubMed ID: 17406717 [TBL] [Abstract][Full Text] [Related]
27. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. Read MA; Wood AA; Harrison JR; Gowan SM; Kelland LR; Dosanjh HS; Neidle S J Med Chem; 1999 Nov; 42(22):4538-46. PubMed ID: 10579817 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents. Taher AT; Hegazy GH Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561 [TBL] [Abstract][Full Text] [Related]
30. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents. Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694 [TBL] [Abstract][Full Text] [Related]
31. 2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action. Kumar S; Hegde M; Gopalakrishnan V; Renuka VK; Ramareddy SA; De Clercq E; Schols D; Gudibabande Narasimhamurthy AK; Raghavan SC; Karki SS Eur J Med Chem; 2014 Sep; 84():687-97. PubMed ID: 25064346 [TBL] [Abstract][Full Text] [Related]
32. Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. Sissi C; Lucatello L; Paul Krapcho A; Maloney DJ; Boxer MB; Camarasa MV; Pezzoni G; Menta E; Palumbo M Bioorg Med Chem; 2007 Jan; 15(1):555-62. PubMed ID: 17035038 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds. Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685 [TBL] [Abstract][Full Text] [Related]
34. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma. Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents. Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives. Teng CH; Won SJ; Lin CN Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds. Kuo SC; Ibuka T; Huang LJ; Lien JC; Yean SR; Huang SC; Lednicer D; Morris-Natschke S; Lee KH J Med Chem; 1996 Mar; 39(7):1447-51. PubMed ID: 8691475 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole. Chen W; Yang XD; Li Y; Yang LJ; Wang XQ; Zhang GL; Zhang HB Org Biomol Chem; 2011 Jun; 9(11):4250-5. PubMed ID: 21505704 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives. Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents. Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]